IP Library Granted Patent US 8,764,712
Granted Patent B2
US 8,764,712 · App. 12/535,314 · Granted Jul 1, 2014

Micro-needle array and method of use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,764,712
App. No.
12/535,314
Granted
Jul 1, 2014
Kind
B2
Abstract

A micro-needle array is provided that may be used to deliver a bioactive agent to a therapeutic target. The micro-needle array preferably includes a substrate, a plurality of micro-needles integral with the substrate, and a bioactive agent. At least one micro-needle preferably includes a top surface, a bottom surface, a side surface, and a cavity defined by an inner surface. The bioactive agent may be disposed on the substrate and the plurality of micro-needles. The at least one micro-needle may further include a slit connecting the cavity to an aperture, the slit extending from the top surface to the bottom surface.

Claims (30)

1. A micro-needle array comprising:

a substrate;

a plurality of micro-needles integral with the substrate, wherein at least one micro-needle comprises a body comprising:

a top surface,

a bottom surface,

a side surface extending from the top surface to the bottom surface, and

a cavity within the body and defined by an inner surface, the cavity extending from the top surface to the bottom surface; and

a bioactive agent disposed on the substrate and the plurality of micro-needles,

wherein the at least one micro-needle further comprises a slit connecting the cavity to an aperture on the side surface, the slit extending from the top surface to the bottom surface,

wherein the slit has a closed configuration and an open configuration.

2. The micro-needle array of claim 1 wherein the cavity has a volume of about 4 cubic microns to about 0.140 cubic millimeters.

3. The micro-needle array of claim 1 wherein the at least one micro-needle has a base length of about 10 μm to about 250 μm and a height of about 10 μm to about 250 μm.

4. The micro-needle array of claim 1 wherein the at least one micro-needle has a passive configuration in which the at least one micro-needle is generally aligned with the substrate and an active configuration in which the at least one micro-needle is generally extending from the substrate.

5. The micro-needle array of claim 1 wherein the at least one micro-needle comprises a material selected from the group consisting of stainless steel alloys and nickel-titanium alloys.

6. The micro-needle array of claim 1 wherein the micro-needle array is disposed on or integrally formed with one of a balloon catheter or a stent.

7. The micro-needle array of claim 1 wherein the bioactive agent is selected from the group consisting of paclitaxel, rapamycin, a rapamycin derivative, an antisense oligonucleotide, and a mTOR inhibitor.

8. The micro-needle array of claim 1 wherein the micro-needle array is fabricated using a process selected from the group consisting of stereolithography, lamininated object manufacturing, selective laser sintering, fused deposition modeling, CNC laser-cutting, and 3-D printing.

9. The micro-needle array of claim 1 wherein the at least one micro-needle has a base length of about 10 μm to about 250 μm and a height of about 10 μm to about 250 μm, wherein the cavity defines a volume of about 4 cubic microns to about 0.140 cubic millimeters, wherein said micro-needle has a passive configuration in which the at least one micro-needle is generally aligned with the substrate and an active configuration in which the at least one micro-needle is generally extending from the substrate, and wherein said micro-needle comprises a material selected from the group consisting of stainless steel alloys and nickel-titanium alloys.

10. The micro-needle array of claim 9 wherein the at least one micro-needle comprises a slit connecting the cavity to an aperture on the side surface, the slit extending from the top surface to the bottom surface.

11. A micro-needle array comprising:

a substrate;

a plurality of micro-needles integral with the substrate, wherein at least one micro-needle comprises a body comprising:

a top surface,

a bottom surface,

a side surface extending from the top surface to the bottom surface, and

a cavity within the body and defined by an inner surface, the cavity extending from the top surface to the bottom surface; and

a bioactive agent disposed on the substrate and the plurality of micro-needles,

wherein the at least one micro-needle has a base length of about 10 μm to about 250 μm and a height of about 10 μm to about 250 μm, wherein the cavity defines a volume of about 4 cubic microns to about 0.140 cubic millimeters, wherein said micro-needle has a passive configuration and an active configuration, and wherein said micro-needle comprises a material selected from the group consisting of stainless steel alloys and nickel-titanium alloys,

wherein the at least one micro-needle comprises a slit connecting the cavity to an aperture on the side surface, the slit extending from the top surface to the bottom surface,

wherein the slit has a closed configuration and an open configuration.

Assignments (1)
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →